Bausch & Lomb Incorporated (NYSE: BLCO), Wilmington, MA – FDA Inspections
Inspection records and compliance data for Bausch & Lomb Incorporated in Wilmington, Massachusetts. 3 FDA inspections on record, 1 Form 483, last inspected August 09, 2018. Publicly traded as NYSE: BLCO.
This profile covers Bausch & Lomb Incorporated based in Wilmington, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected April 18, 2011. Last inspected August 9, 2018.
Most cited issue areas
- Documentation1 inspection
- Lack of or inadequate complaint procedures1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 9, 2018 | Not classified | Medical Devices & Rad Health | 1157054 |
| July 31, 2013 | VAI | Medical Devices & Rad Health · Compliance: Devices | 843014 |
| April 18, 2011 | NAI | Medical Devices & Rad Health · Compliance: Devices | 720310 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Bausch & Lomb Incorporated
Stock ticker
BLCO
Exchange
NYSE
Share price
$19.96
Market cap
$7.1B
Price as of
November 6, 2026
FEI Number
1281950
Address
100 Research Dr, Wilmington, Massachusetts 01887, United States
Country
United States
ID: 8888b9c7-4ddb-41e5-97e2-63c3ac4578a3